Literature DB >> 2790740

Characterization of three human malignant mesothelioma cell lines.

M A Versnel1, H C Hoogsteden, A Hagemeijer, M J Bouts, T H van der Kwast, M Delahaye, G Schaart, F C Ramaekers.   

Abstract

Three human malignant mesothelioma cell lines, designated Mero-14, Mero-25, and Mero-41, have been isolated from effusions and from autopsy material of confirmed cases of malignant mesothelioma. Light and electron microscopy, cytogenetics, growth requirements, and intermediate filament expression of these cell lines were studied and, where possible, compared with the original tumor material of the patient. Cytologic and ultrastructural morphology was consistent with the mesothelial nature of the cells. All cell lines displayed a hyperdiploid karyotype similar to that of the tumor cells obtained directly from the patient. All three malignant mesothelioma cell lines had marker chromosomes 1, 3, 9, and 22, as well as other markers that were occasionally present in these cell lines and in other malignant mesotheliomas studied. Growth kinetic studies in medium supplemented with epidermal growth factor (EGF) showed increased proliferation and a decreased proliferation in medium supplemented with hydrocortisone (HC) or EGF plus HC. The three malignant mesothelioma cell lines were positive for the cytokeratins 7, 8, 18, and 19 based on immunofluorescence and immunoblotting tests with chain-specific monoclonal antibodies. The characteristics of these cell lines support the assumption that Mero-14, Mero-25 and Mero-41 are derived from malignant mesotheliomas and have retained their original character.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2790740     DOI: 10.1016/0165-4608(89)90014-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  LRRN4 and UPK3B are markers of primary mesothelial cells.

Authors:  Mutsumi Kanamori-Katayama; Ai Kaiho; Yuri Ishizu; Yuko Okamura-Oho; Okio Hino; Masaaki Abe; Takumi Kishimoto; Hisahiko Sekihara; Yukio Nakamura; Harukazu Suzuki; Alistair R R Forrest; Yoshihide Hayashizaki
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

2.  Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines.

Authors:  E M van Schothorst; S Mohkamsing; R J van Gurp; J W Oosterhuis; P T van der Saag; L H Looijenga
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

3.  MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Authors:  Ombretta Melaiu; Justin Stebbing; Ylenia Lombardo; Elisa Bracci; Norihisa Uehara; Alessandra Bonotti; Alfonso Cristaudo; Rudy Foddis; Luciano Mutti; Roberto Barale; Federica Gemignani; Georgios Giamas; Stefano Landi
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

4.  Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene.

Authors:  Alessandra Fazzini; Vanessa D'Antongiovanni; Laura Giusti; Ylenia Da Valle; Federica Ciregia; Ilaria Piano; Antonella Caputo; Anna Maria D'Ursi; Claudia Gargini; Antonio Lucacchini; Maria Rosa Mazzoni
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

5.  Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.

Authors:  Chiara De Santi; Sebastian Vencken; Jonathon Blake; Bettina Haase; Vladimir Benes; Federica Gemignani; Stefano Landi; Catherine M Greene
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells.

Authors:  Maureen Keller; Katarina Reis; Anders Hjerpe; Katalin Dobra; Pontus Aspenström
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.